The absence of obesity, diabetes and hypertension in middle age was associated with significantly fewer years lived with heart failure, according to a Northwestern Medicine study.
Northwestern Medicine scientists have demonstrated an alternate method of signaling used by proteins called group I metabotropic glutamate receptors, a finding that could be used to develop novel drug treatments for many neurological disorders.
Coronary artery calcium — a sign of atherosclerosis — was found in more than one-third of women previously considered to be low-risk for heart disease, according to a Northwestern Medicine study.
Northwestern University synthetic biologists have developed a general method for “rewiring” immune cells to help overcome immunosuppression in cancer.
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
Northwestern University faculty rank highly among the most-cited researchers globally, according to a list curated by Clarivate Analytics.
Second-year medical students presented their in-progress research projects at the Area of Scholarly Concentration poster session.
Bruce Henschen, ’12 MD, ’12 MPH, ’15 GME, assistant professor of Medicine in the Division of General Internal Medicine and Geriatrics, has received the Thomas Hale Ham Award for New Investigators.
Northwestern Medicine scientists have identified one of the molecular mechanisms behind the variability of holoprosencephaly, a congenital brain malformation.